Search Results - "Wakil, G"

Second malignancies after permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003 by Cosset, J.-M., Belin, L., Wakil, G., Flam, T., Thiounn, N., Pierrat, N., Pontvert, D., Savignoni, A., Chauveinc, L.

“…To analyse the rate of secondary malignancies observed in a series of 675 prostate cancer patients who underwent a permanent implant brachytherapy between 1999…”
Get full text

Long-term results of permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003 by Cosset, J.-M., Flam, T., Belin, L., Thiounn, N., Pierrat, N., Pontvert, D., Wakil, G., Savignoni, A., Chauveinc, L.

“…To analyse long-term overall survival, relapse-free survival and late toxicities in a series of 675 patients treated between 1999 and 2003, with a median…”
Get full text

761 poster IMPLANT BREAST RECONSTRUCTION FOLLOWED BY RADIOTHERAPY: CAN THE TOMOTHERAPY BECOME A STANDARD OF IRRADIATION? by Massabeau, C, Fournier-Bidoz, N, Wakil, G, Fourquet, A, Zefkili, S, Kirova, Y

Get full text

710 poster FOCAL BRACHYTHERAPY FOR PROSTATE CANCER: A PILOT STUDY by Cosset, J.M, Wakil, G, Pierrat, N, Cathelineau, X, Marchand, V, Vallancien, G

Get full text

Impact of the Radiation Dose Delivered to the Inner Ear on Hearing Loss in Head and Neck Cancer Patients by Wakil, G, Al-Shemari, H, Cury, F, Hier, M.P, Black, M.J, Sultanem, K

Get full text

There is no difference in the disease severity of gastro‐oesophageal reflux disease between patients infected and not infected with Helicobacter pylori by Fallone, C. A., Barkun, A. N., Mayrand, S., Wakil, G., Friedman, G., Szilagyi, A., Wheeler, C., Ross, D.

“…Summary Background : The role of Helicobacter pylori in gastro‐oesophageal reflux disease (GERD) is controversial. Aim : To compare the severity of GERD in…”
Get full text

Multimodality Image Registrations for Combined MRI/CT HDR Prostate Brachytherapy: The Concept of the Iurethra by Jolicoeur, M., Derashodian, T., Last, J., Wakil, G., Mondat, M.

Get full text

Patient-Reported Quality of Life in Low and Intermediate Risk Prostate Cancer Patients Randomized a Phase II Randomized Trial of HDR Brachytherapy As Monotherapy (BRP2) by Jolicoeur, M., Nguyen-Huynh, T.V., Derashodian, T., de Castro Hellmann, E., Wakil, G., Nachabe, M., Antebi, E., Héliou, R.

Get full text

V150 and Urethral Dmax Predict Radiation Induced Prostatitis by Derashodian, T., Le, M., Mondat, M., Wakil, G., Last, J., Jolicoeur, M.

Get full text

OC-0282 HDR brachytherapy Monotherapy for prostate cancer: a one-day schedule phase II trial acute toxicity by Jolicoeur, M., Nguyen, T.V., Derashodian, T., Hill, E., Mondat, M., Nachabe, M., Antebi, E., Wakil, G., Héliou, R.

Get full text

High-Dose-RATE Brachytherapy As Monotherapy for Low and Intermediate Risk Prostate Cancer: ACUTE Toxicity of a Randomized Phase II Trial by Jolicoeur, M., Derashodian, T., Nguyen-Huynh, T.V., de Castro Hellmann, E., Mondat, M., Nachabe, M., Antebi, E., Wakil, G., Héliou, R.

Get full text